What is Forte Biosciences Inc (FBRX) stock price today?

Forte Biosciences Inc (FBRX) currently trades at $28.03 per share. The stock has a market capitalization of $537.90M and a P/E ratio of —x.

Is FBRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Forte Biosciences Inc has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -2.80.

Is Forte Biosciences Inc financially healthy?

Forte Biosciences Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -2.80 places it in the distress.

FBRX

Forte Biosciences Inc

NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY

$28.03

+6.23% today

Updated 2026-04-29

Market cap

$537.90M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$6 – $36

Volume

0.3M

Market cap

$537.90M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$6 – $36

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-2.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$63.75

+127.43%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -2.80 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-16.47M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-13.86M	$-31.48M	$-35.48M	$-69.38M	$-24.79M
EPS	—	—	—	—	$-4.71
Free cash flow	$-8.19M	$-28.79M	$-30.78M	$-51.00M	$-16.47M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-01	WAGNER, PAUL A.	Sale	1,250	—
2026-04-01	WAGNER, PAUL A.	Buy	1,250	—
2026-04-01	WAGNER, PAUL A.	Sale	98	$24.86

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FBRX	$537.90M	22	4.3	3.0	5.0	4.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Forte Biosciences Inc trades at $28.03. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.80, it sits in the distress.

Frequently asked questions

What is Forte Biosciences Inc's stock price?

Forte Biosciences Inc (FBRX) trades at $28.03.

Is Forte Biosciences Inc overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Forte Biosciences Inc (FBRX)?

The analyst target price is $63.75, representing +127.4% upside from the current price of $28.03.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-2.80 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-122.30%

Beta3.20

50D MA$28.71

200D MA$20.25

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week-8.58%

1 month+1.87%

3 months-9.70%

YTD-3.25%

1 year—

3 years—

5 years—

Compare

FBRX vs LLY →FBRX vs JNJ →FBRX vs ABBV →Stock screener →